Validation of genotype array analysis for the assessment of homologous recombination deficiency (HRD) in epithelial ovarian cancer

被引:0
|
作者
Schnaiter, Simon [1 ]
Schamschula, Esther [1 ]
Zschocke, Johannes [1 ]
Fiegl, Heidi [2 ]
Reimer, Daniel U. [2 ]
Zeimet, Alain [2 ]
Wimmer, Katharina [1 ]
机构
[1] Med Univ Innsbruck, Inst Human Genet, Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P13.091.A
引用
收藏
页码:555 / 556
页数:2
相关论文
共 50 条
  • [21] Homologous Recombination Deficiency (HRD) in Hematological Malignancies
    Sahajpal, Nikhil
    Kota, Vamsi K.
    Jillella, Anand P.
    Mondal, Ashis
    Kolhe, Ravindra
    BLOOD, 2022, 140 : 11839 - 11840
  • [22] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Ratnaparkhi, Rubina
    Javellana, Melissa
    Jewell, Andrea
    Spoozak, Lori
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (02) : 237 - 260
  • [23] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Rubina Ratnaparkhi
    Melissa Javellana
    Andrea Jewell
    Lori Spoozak
    Current Treatment Options in Oncology, 2024, 25 : 237 - 260
  • [24] Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
    Akinjiyan, Favour A.
    Morecroft, Renee
    Phillipps, Jordan
    Adeyelu, Tolulope
    Elliott, Andrew
    Park, Soo J.
    Butt, Omar H.
    Zhou, Alice Y.
    Ansstas, George
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [25] Homologous recombination deficiency (HRD) testing on cell-free tumor DNA in ascites of patients with newly diagnosed advanced epithelial ovarian cancer
    Roussel-Simonin, Cyril
    Blanc-Durand, Felix
    Roueau, Etienne
    Le Formal, Audrey
    Chardin, Laure
    Yaniz, Elisa
    Gouy, Sebastien
    Maulard, Amandine
    Cherrier, Stephanie
    Sanson, Claire
    Mauny, Lea
    Coterret, Sophie
    Zaccarini, Francois
    Tang, Roseline
    Leary, Alexandra
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
    Chiang, Ying-Cheng
    Lin, Po-Han
    Cheng, Wen-Fang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] ctDNA from ascites as an alternative to tumor sampling for HRD (homologous recombination deficiency) testing in ovarian cancer (OC).
    Leary, Alexandra
    el Hazzaz, Reda
    Le Formal, Audrey
    Lecerf, Elodie
    Brizais, Chloe
    Blameble, Emeline Colomba
    Gouy, Sebastien
    Maulard, Amandine
    Boursin, Yannick
    Pautier, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Assessment of the RAD51 test to determine homologous recombination deficiency (HRD) in patients with newly diagnosed advanced high-grade epithelial ovarian cancer carcinoma (HGOC)
    Garcia-Duran, Carmen
    Domenech, Heura
    Villacampa, Guillermo
    Grau-Bejar, Juan Francisco
    Llop-Guevara, Alba
    Garcia-Illescas, David
    Mazzeo, Roberta
    Simonetti, Sara
    Farinas-Madrid, Lorena
    Musacchio, Lucia
    Serra, Violeta
    Oaknin, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A504 - A505
  • [29] Radiogenomics of homologous recombination deficiency (HRD) in breast cancer: Radiomics-based image biomarker for HRD
    Lim, Joonoh
    Paik, Pill Sun
    Lee, Jeongmin
    Oh, Brian Baek-Lok
    Kim, Ryul
    Ju, Young Seok
    Lee, Jeong Seok
    Kwon, Minsuk
    Lee, Sangmoon
    Lee, Won-Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Homologous recombination deficiency (HRD) in patients with pancreatic cancer (PC) and response to chemotherapy
    Shahda, Safi
    Timms, Kirsten
    Ibrahim, Ashley
    Reid, Julia E.
    Cramer, Harvey M.
    Radovich, Milan
    Ibrahim, Sulfikar
    Allen, Brian
    O'Neil, Bert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)